Back
Relmada Therapeutics, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
32
RLMD
Relmada Therapeutics, Inc.
Last Price:
$3.99
Seasonality Move:
6.46%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and RLMD is experiencing slight buying pressure.
Relmada Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.22 | Sell |
| 20-day SMA: | 3.9 | Buy |
| 50-day SMA: | 2.87 | Buy |
| 200-day SMA: | 1.19 | Buy |
| 8-day EMA: | 4.14 | Sell |
| 20-day EMA: | 3.82 | Buy |
| 50-day EMA: | 2.85 | Buy |
| 200-day EMA: | 1.13 | Buy |
Relmada Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 60.15 | Buy |
| Chaikin Money Flow: | 366058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.83 - 4.39) | Buy |
| Bollinger Bands (100): | (0.71 - 3.11) | Buy |
Relmada Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics, Inc. Stock
Is Relmada Therapeutics, Inc. Stock a Buy?
-
Relmada Therapeutics, Inc. share price is 4.00 while RLMD 8-day simple moving average is 4.22, which is a Sell signal.
-
The stock price of RLMD is 4.00 while Relmada Therapeutics, Inc. 20-day SMA is 3.90, which makes it a Buy.
-
Relmada Therapeutics, Inc. 50-day simple moving average is 2.87 while RLMD share price is 4.00, making it a Buy technically.
-
RLMD stock price is 4.00 and Relmada Therapeutics, Inc. 200-day simple moving average is 1.19, creating a Buy signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
32
Relmada Therapeutics, Inc. (RLMD)
is a Sell
Is Relmada Therapeutics, Inc. a Buy or a Sell?
-
Relmada Therapeutics, Inc. stock is rated a SellThe current Relmada Therapeutics, Inc. [RLMD] share price is $4.00. The Score for RLMD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics, Inc. Stock Info
Market Cap:
293.3M
Price in USD:
4.00
Share Volume:
878.5K
Relmada Therapeutics, Inc. 52-Week Range
52-Week High:
5.12
52-Week Low:
0.24
Sell
32
Relmada Therapeutics, Inc. (RLMD)
is a Sell
Relmada Therapeutics, Inc. Share Price Forecast
-
What is the Relmada Therapeutics, Inc. stock price today?The Relmada Therapeutics, Inc. stock price is 4.00 USD today.
-
Will RLMD stock go up or go down?Relmada Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Relmada Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics, Inc. is overvalued.
Is Relmada Therapeutics, Inc. Stock a Buy?
-
Relmada Therapeutics, Inc. share price is 4.00 while RLMD 8-day exponential moving average is 4.14, which is a Sell signal.
-
The stock price of RLMD is 4.00 while Relmada Therapeutics, Inc. 20-day EMA is 3.82, which makes it a Buy.
-
Relmada Therapeutics, Inc. 50-day exponential moving average is 2.85 while RLMD share price is 4.00, making it a Buy technically.
-
RLMD stock price is 4.00 and Relmada Therapeutics, Inc. 200-day simple moving average is 1.13, creating a Buy signal.
Fundamental Analysis of Relmada Therapeutics, Inc.
Is Relmada Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.47 per share.
Technical Analysis of Relmada Therapeutics, Inc.
Should I short Relmada Therapeutics, Inc. stock?
-
RLMD Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting Relmada Therapeutics, Inc. is a Buy
-
Relmada Therapeutics, Inc. Relative Strength Index (RSI) is 60.15, which suggest Relmada Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Relmada Therapeutics, Inc. is (2.83 - 4.39), which suggest Relmada Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Relmada Therapeutics, Inc. is (0.71 - 3.11), which suggest Relmada Therapeutics, Inc. is a Buy
* Relmada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.